Related Experiment Videos
Plasmapheresis in newborns with hyperbilirubinemia
R Bambauer1, R el-Saadi, N Graf
1Department of Nephrology, University of Saarland, Homburg/Saar, Germany.
Artificial Organs
|October 1, 1992
Summary
This study shows a miniaturized system effectively treated 15 infants with hyperbilirubinemia using plasmapheresis, significantly lowering bilirubin levels. Most infants improved, demonstrating the system
Area of Science:
- Neonatal Medicine
- Pediatric Nephrology
- Extracorporeal Therapies
Background:
- Hyperbilirubinemia and Rh erythroblastosis pose significant risks to premature infants and newborns.
- Traditional extracorporeal detoxification methods may present challenges in neonatal applications.
Purpose of the Study:
- To evaluate the efficacy and safety of a miniaturized plasmapheresis system for treating neonatal hyperbilirubinemia.
- To assess the impact of extracorporeal detoxification on serum bilirubin levels in premature infants and newborns.
Main Methods:
- A miniaturized plasmapheresis system with a double head pump and balancing pump was utilized.
- Treatments included plasmapheresis, hemofiltration, and hemodialysis in 15 neonates (average birth weight 2,386 g).
- Vascular access was achieved via umbilical or femoral vein catheters, with a main blood flow of 5.3 ml/min and filtrate flow of 1.3 ml/min.
Main Results:
- An average of 192.4 ml of plasma was exchanged per treatment.
- 1 to 10 treatments reduced mean serum bilirubin from 15.6 ± 4.8 mg/dl to 7.3 ± 3.2 mg/dl.
- Serum bilirubin normalized, and 12 out of 15 infants improved; 3 infants died due to primary disease and prematurity.
Conclusions:
- The miniaturized plasmapheresis system is a well-tolerated and effective treatment for neonatal hyperbilirubinemia.
- This technology offers a viable option for extracorporeal detoxification in high-risk infant populations.
- Further research may explore optimizing treatment protocols for specific neonatal conditions.